SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-003310
Filing Date
2021-05-07
Accepted
2021-05-07 16:18:32
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcrx20210331_10q.htm   iXBRL 10-Q 1186079
2 EXHIBIT 10.1 ex_247203.htm EX-10.1 128606
3 EXHIBIT 10.2 ex_247204.htm EX-10.2 40930
4 EXHIBIT 31.1 ex_245740.htm EX-31.1 12902
5 EXHIBIT 31.2 ex_245741.htm EX-31.2 12900
6 EXHIBIT 32.1 ex_245742.htm EX-32.1 5883
7 EXHIBIT 32.2 ex_245743.htm EX-32.2 5857
  Complete submission text file 0001171843-21-003310.txt   6301100

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20210331.xsd EX-101.SCH 61169
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20210331_cal.xml EX-101.CAL 35122
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20210331_def.xml EX-101.DEF 433325
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20210331_lab.xml EX-101.LAB 397360
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20210331_pre.xml EX-101.PRE 445512
13 EXTRACTED XBRL INSTANCE DOCUMENT bcrx20210331_10q_htm.xml XML 914496
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 21902949
SIC: 2836 Biological Products, (No Diagnostic Substances)